Skip to Content

Danaher Corp DHR

Morningstar Rating
$249.72 +0.95 (0.38%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Danaher Has Spun Off the Veralto Assets to Shareholders

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand within those fields and divest assets that are no longer seen as core, such as the recently divested Veralto operations. After acquisitions, Danaher aims to accelerate core growth at acquired companies by making research and development and marketing-related investments. It also implements lean manufacturing principles and administrative cost controls to boost operating margins. Overall, we appreciate Danaher's strategic moves, which have pushed it into attractive end markets with strong growth prospects and sticky, recurring revenue streams.

Price vs Fair Value

DHR is trading at a 2% premium.
Price
$247.80
Fair Value
$991.00
Uncertainty
Medium
1-Star Price
$843.61
5-Star Price
$215.30
Economic Moat
Thmrb
Capital Allocation
Gygqpbmvj

Bulls Say, Bears Say

Bulls

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.

Bears

Danaher continues to hunt for acquisitions in the life sciences and diagnostics markets, which could constrain ROICs including goodwill if it makes acquisitions at unattractive prices and is not able to integrate them as successfully as in the past.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DHR is a good fit for your portfolio.

Trading Information

Previous Close Price
$248.77
Day Range
$247.20251.06
52-Week Range
$182.09259.00
Bid/Ask
$249.43 / $250.42
Market Cap
$184.72 Bil
Volume/Avg
2.6 Mil / 2.5 Mil

Key Statistics

Price/Earnings (Normalized)
29.20
Price/Sales
7.74
Dividend Yield (Trailing)
0.42%
Dividend Yield (Forward)
0.43%
Total Yield
0.42%

Company Profile

In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Core
Total Number of Employees
63,000

Competitors

Valuation

Metric
DHR
RHHBY
MRK
Price/Earnings (Normalized)
29.2011.7220.03
Price/Book Value
3.445.832.61
Price/Sales
7.743.053.32
Price/Cash Flow
26.8611.2315.51
Price/Earnings
DHR
RHHBY
MRK

Financial Strength

Metric
DHR
RHHBY
MRK
Quick Ratio
1.180.990.79
Current Ratio
1.681.351.42
Interest Coverage
17.5814.9311.32
Quick Ratio
DHR
RHHBY
MRK

Profitability

Metric
DHR
RHHBY
MRK
Return on Assets (Normalized)
5.68%17.03%7.55%
Return on Equity (Normalized)
9.47%53.42%13.81%
Return on Invested Capital (Normalized)
6.69%26.30%10.19%
Return on Assets
DHR
RHHBY
MRK
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncBtnjmjnwrWzth$220.9 Bil
IQV
IQVIA Holdings IncKpddjqcfyQrhyws$46.0 Bil
IDXX
IDEXX Laboratories IncDsftpxwrlgGwlzjp$44.8 Bil
A
Agilent Technologies IncYlqwgwdxWpth$43.2 Bil
MTD
Mettler-Toledo International IncRrxjrwrlwfRdxhld$28.6 Bil
ICLR
Icon PLCXpvmmrcxCjdqwb$27.2 Bil
ILMN
Illumina IncHgrybptsDwsqmj$22.0 Bil
WAT
Waters CorpJvxgsjltsKyrj$20.4 Bil
LH
Laboratory Corp of America HoldingsFctzjmgfccLzdbsy$18.2 Bil

Sponsor Center